Prion risk eliminated

DUPONT RelyOn Prion Inactivator will significantly reduce the potential risk of iatrogenic transmission of vCJD via surgical instruments and medical devices. Standard decontamination and sterilising procedures do not effectively remove the infectivity of prion proteins.

Used as a short pre-wash prior to standard decontamination, RelyOn Prion Inactivator gives at least 1,000,000 fold reduction in prion infectivity as proven by bio-assay and Western Blot techniques.

RelyOn Prion Inactivator is a patented combination of proteolytic enzymes, a surface active agent and a reaction potentiator resulting in a rapidly effective, pH neutral solution.

RelyOn Prion Inactivator not only reduces prion infectivity, but has a full range of microbiocidal efficacy and therefore provides operator safety for handling of instruments.

It addresses the concerns for iatrogenic transmission of vCJD expressed in the recent NICE Guidance and offers the NHS a simple and proven means to reduce the risk of secondary vCJD infections.

Latest Issues

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026

AfPP Annual National Conference 2026

Wyboston Lakes Resort
7th – 8th August 2026

The Annual Operating Theatres Show

Manchester (Etihad)
10th September 2026

AfPP Regional Conferences: London

Cavendish Conference Centre
12th September 2026

CSC Autumn Study Day 2026

Holiday Inn, Birmingham Airport - NEC by IHG
12th October 2026